Saco agency to establish state's 1st locked residential psychiatric treatment center for children
Mar. 27—Maine's Department of Health and Human Services has contracted with a Saco-based behavioral health agency to build the state's first adolescent residential treatment program, a development advocates believe will help close an important gap in services for vulnerable children.
Sweetser was awarded a $2 million contract this month, CEO Jayne Van Bramer said, and the organization hopes to open a 16-bed facility in April 2026.
"Being able to have an available locked residential program for children who require that level of service is long overdue," she said in an interview Thursday. "The absence of that has resulted in children being sent out of state, away from family, languishing in emergency rooms for weeks or months at a time."
The state, under Gov. Janet Mills, has been working for years to establish a secure psychiatric treatment center for children, even as some advocates have warned that a locked facility is a step backward in how systems treat people with behavioral and mental health diagnoses.
But Van Bramer said as many as 35 other states already have similar facilities, and Maine has been sending many children out of state already.
"This can really be a win for families and children and really a win for Maine," she said.
Maine does have a network of residential programs for children, but all are unlocked and often unable to provide adequate resources for clients who might be aggressive or dangerous. They also typically have long waiting lists.
As a result, children with high behavioral health needs often end up in hospitals by default or sent out of state, both of which are costly for the state.
Sweetser is one of the state's largest mental health providers, both for children and adults, with locations in nine communities. It was the only agency that submitted a bid to the DHHS for start-up funds. It plans to use them to renovate an existing building on its Saco campus.
Although the state has entered into an agreement with Sweetser to create a new facility, some advocates and lawmakers believe demand is high enough to create even more. Sen. Joseph Baldacci, D-Bangor, has sponsored a bill to create a psychiatric residential treatment facility as well as three "crisis centers" where children could stay after being discharged from a hospital. That bill had a public hearing this week.
Van Bramer said it will be up to the state to determine who would qualify for placement in the new facility — children with advanced behavioral or mental health needs are typically covered by MaineCare — but she agreed that filling the beds will not be a challenge.
"This is not meant to be a long-term program, though," she said. "We hope that children can step down into other residential placements or return home entirely."
Maine has struggled for years to adequately provide both in-home and residential care for children with advanced behavioral needs, a problem that has worsened in recent years because of workforce shortages.
Last year, the U.S. Department of Justice sued the state of Maine for allegedly violating the civil rights of disabled children. Among the allegations were that the state failed to invest in community-based providers and that it has been "unnecessarily segregating children with behavioral health disabilities in hospitals, residential facilities and a state-operated juvenile detention facility."
That resulted in a settlement that required the state to strengthen its community-based services for children with behavioral health challenges to keep them from being placed outside the home. The creation of a locked facility was not a requirement of that settlement, but it will help the state address some of the deficiencies cited by the Justice Department.
This story will be updated
Copy the Story Link
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
8 hours ago
- New York Post
Nationwide recall issued for popular chocolate brand that contains potentially ‘life-threatening' ingredient
A popular chocolate treat is being pulled from shelves nationwide over an ingredient that may trigger severe – and potentially deadly – allergic reactions, federal officials warned. An urgent recall was issued after Lipari Foods discovered that its 14-ounce packages of JLM Branded Dark Chocolate Nonpareils may contain undeclared milk, the US Food and Drug Administration (FDA) announced Friday. Those with milk allergies are urged to avoid consuming the potentially lethal candy. Select packages of JLM Branded Dark Chocolate Nonpareils may contain undeclared milk. USFDA 'People who have allergies to milk run the risk of serious or life-threatening allergic reactions if they consume these products,' the dire bulletin stated. The Michigan-based company initiated the recall after its distributor, Weave Nut Company, alerted them that the candy may contain the dairy allergen, which was not disclosed on the packaging. But the sprinkle-topped chocolate discs, sold in clear plastic tubs, had already made their way to retailers across the country. The recall targets packaging with lot codes 28202501A, 29202501A, 23202504A, 14202505A, 15202505A, and 03202506A on the bottom label. No illnesses or adverse reactions have been reported in connection with the recall. Brent Hofacker – The FDA advised customers to return the product to the place of purchase for a full refund. No illnesses or adverse reactions have been reported in connection with the recall.
New York Post
16 hours ago
- New York Post
Grieving parents awarded $2.25M after Georgia doctor plastered videos of their decapitated baby on social media
A Georgia couple whose baby was decapacitated during childbirth was awarded a $2.25 million verdict after their pathologist posted graphic autopsy videos on social media without their consent. Dr. Jackson Gates and his Atlanta-based business will have to fork over the large sum to Jessica Ross and Traveon Taylor Sr. after a Fulton County jury found him liable of emotional distress, invasion of privacy, and fraud on Wednesday. 'This young couple trusted him with the remains of their precious baby,' attorney's for the grieving parents said, noting that the doctor 'poured salt into the couple's already deep wounds.' 3 Jessica Ross and Treveon Taylor Sr., parents of a baby who was decapitated during childbirth. AP 'Gates, in turn, repaid this trust by posting horrific images of their child for the world to see.' The heartbroken couple hired the twisted doctor to perform an autopsy on their deceased newborn two days after their obstetrician allegedly applied excessive force to the baby's neck when its shoulders became stuck in Ross's pelvic area, causing it to detach during the traumatic July 2023 delivery. 3 The traumatic delivery occurred at Southern Regional Medical Center in July 2023. ERIK S LESSER/EPA-EFE/Shutterstock The baby's head was delivered vaginally, but the rest of the body was removed via C-section. The death was later ruled a homicide. Gates posted numerous videos and photos to his Instagram later that month, showing the grisly postmortem examination of their infants 'decapitated, severed head,' the couple said in their lawsuit. The deranged pathologist initially removed the footage after receiving a letter from the couple's attorney — but later reposted them, according to the lawsuit. 3 The couple was awarded $2.25 million in a lawsuit against their pathologist. AP Gates' attorney, Ira Livant, said his client typically documents his autopsy's on social media to educate fellow pathologists and highlight the importance of independent examinations in cases where families suspect medical misconduct. 'Dr. Gates testified that he is deeply sorry for any harm that he unintentionally caused the plaintiffs,' Livant said Saturday. 'Had he known for one second that they would see that and that they would know it was their child, he would never have done it.' The couple will receive $2 million in compensatory damages and an additional $250,000 in punitive damages from Gates and his company, Medical Diagnostics Choices, per the judgement. The bereaved parents have separate lawsuits pending against the delivering doctor and the Riverdale hospital where the horrific incident took place. With Post wires.
UPI
19 hours ago
- UPI
NIH office to phase out HIV guidelines by next year
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States is making major changes. File Photo by Annabelle Gordon/UPI | License Photo June 21 (UPI) -- The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States is making major changes. The NIH Office of AIDS Research or OAR told its employees this week it intends to phase out the guidelines by next June, the Washington Post reported, citing an internal staff email. According to the office, OAR "coordinates HIV/AIDS research across the National Institutes of Health and provides the largest public investment in HIV/AIDS research globally." "In the climate of budget decreases and revised priorities, OAR is beginning to explore options to transfer management of the guidelines to another agency within" the letter obtained by The Post reads. The OAR guidelines contain guidelines related to diagnosis and treatments of HIV and AIDS. There are currently more than 1 million people living with HIV in the United States. It was not immediately clear what the other agency referred to in the letter was or how such a move may affect the guideline, the Post reported. The news comes as President Donald Trump and Secretary of State Marco Rubio move to cut over $8 billion from the U.S. Agency for International Development, USAID and merge it into the State Department. State Department officials say the move comes with the expectation that other countries will increase their roles in delivering aid around the world. An April report published in the Lancet medical journal found around half a million children globally could die from AIDS by 2030 if the United States cuts its global relief funding. Earlier this week, the U.S. Food and Drug Administration approved use of the HIV drug lenacapavir, which is produced by California-based biopharma firm Gilead Sciences under the name Yeztugo. "Yeztugo is one of the most important scientific breakthroughs of our time and offers a very real opportunity to help end the HIV epidemic," Gilead Science Chairman and Chief Executive Officer Daniel O'Day said in a statement on the company's website
